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(57) ABSTRACT 
A method and apparatus for electronically performing a 
visual field test for a patient. A visual field test pattern is 
displayed to the patient on an electronic display device and 
the patient’s responses to the visual field test pattern are 
recorded. A visual field representation is generated from the 
patient’s responses. The visual field representation is then 
used as an input into a variety of automated diagnostic 
processes. In one process, the visual field representation is 
used to generate a statistical description of the rapidity of 
change of a patient’s visual field at the boundary of a visual 
field defect. In another process, the area of a visual field 
defect is calculated using the visual field representation. In 
another process, the visual field representation is used to 
generate a statistical description of the volume of a patient’s 
visual field defect. 
18 Claims, 21 Drawing Sheets 
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AUTOMATED OBJECTIVE 
CHARACTERIZATION OF VISUAL FIELD 
DEFECTS IN 3D 
CROSS-REFERENCE TO RELATED 
APPLICATION 
The present application claims the benefit of U.S. Provi- 
sional Patent Application No. 601379,155, filed May 3, 
2002, and is a continuation-in-part of co-pending U.S. patent 
application Ser. No. 101178,966, filed Jun. 25, 2002, now 
issued as U.S. Pat. No. 6,769,770 on Aug. 3, 2004, which is 
a continuation-in-part of co-pending U.S. patent application 
Ser. No. 091820,283, filed Mar. 27,2001, now issued as U.S. 
Pat. No. 6,578.966 on Jun. 17, 2003, which claims the 
benefit of U.S. Provisional Application No. 6011 92,645, filed 
Mar. 27, 2000, U.S. Provisional Application No. 601204, 
362, filed May 15, 2000, U.S. Provisional Application No. 
601250,901, filed Dec. 1, 2000, and U.S. Provisional Appli- 
cation No. 601251,957, filed Dec. 7,2000, each of which are 
expressly incorporated by reference as though fully set forth 
in full herein. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
The U.S. Government has certain rights in this invention 
pursuant to grant PHY-9722428 awarded by the National 
Science Foundation and 01 STCR R.03.021.048 awarded by 
NASA. 
BACKGROUND OF THE INVENTION 
This invention relates generally to the field of medical 
instrumentation and more specifically to the automated 
detection of defects of the retina, the optic nerve, and the 
brain’s visual pathways. 
A large number of medical ailments manifest themselves 
as defects in a patient’s visual field. Patients suffering from, 
for example, macular degeneration, anterior ischemic optic 
neuropathy (AION), glaucoma, optic neuritis, detached 
retina, macular edema, central or branch retinal artery occlu- 
sion, some genetic impairments, and brain tumors may 
experience losses in visual acuity and visual field. 
Non-invasive methods to measure a patient’s visual field 
have been developed. For example, perimetry and campim- 
etry provide information pertaining to the borderline 
between seeing and non-seeing areas within a patient’s 
visual field. 
Visual field tests employing visual field test patterns, such 
as an Amsler grid, have been developed to give a qualitative 
analysis of a patient’s visual field. However such tests do not 
provide data of sufficient resolution or precision to perform 
a quantitative analysis of a patient’s condition. 
Recent developments of testing methods using visual field 
test patterns have included adjusting a patient’s perception 
of the contrast levels within a visual field test pattern. For 
example, a method disclosed in U.S. Pat. No. 4,818,091, the 
disclosure of which is hereby incorporated by reference, 
requires the use of eyeglasses with polarized lenses to adjust 
the apparent contrast level of an Amsler grid. 
These methods suffer from a variety of problems. Some 
methods require a patient to endure a long and boring testing 
process during which time the patient’s concentration may 
lag because of fatigue. Other methods, while capable of 
being quickly performed, do not provide the spatial and 
contrast resolution required for high quality quantitative 
analysis. 
2 
Therefore, a need exists for a method that is quicker, 
simpler and more revealing than existing methods for char- 
acterizing the visual field. The present invention meets such 
need. 
5 
SUMMARY OF THE INVENTION 
In various aspects of the invention, a method and appa- 
ratus for electronically performing a visual field test for a 
patient are provided. A visual field test pattern is displayed 
to the patient on an electronic display device and the 
patient’s responses to the visual field test pattern are 
recorded. A visual field representation is generated from the 
15 patient’s responses. The visual field representation is then 
used as an input into a variety of automated diagnostic 
processes. In one diagnostic process, the visual field repre- 
sentation is used to generate a statistical description of the 
rapidity of change of a patient’s visual field at the boundary 
20 of a visual field defect. In another diagnostic process, the 
area of a visual field defect is calculated using the visual 
field representation. In another diagnostic process, the visual 
field representation is used to generate a statistical descrip- 
tion of the volume of a patient’s visual field defect. 
In one aspect of the invention, a data processing apparatus 
for objectively characterizing a patient’s visual field, 
includes a processor and a memory coupled to the processor 
and having program instructions executable by the processor 
30 stored in the memory. The program instructions include 
repeating the following steps a and b for a plurality of 
varying contrast levels and a plurality of corresponding 
patient response signals: a) presenting a visual field test 
pattern to the patient using an electronic display device, the 
35 visual field test pattern presented at a contrast level selected 
from the plurality of varying contrast levels; and b) receiv- 
ing a corresponding patient response signal. The data pro- 
cessing system then generates a characterization of the 
patient’s visual field using the plurality of contrast levels and 
In another aspect of the invention the characterization 
includes a statistical description of a boundary of a visual 
field defect. 
In another aspect of the invention, the statistical descrip- 
tion includes a percentage of retinal contrast sensitivity loss 
over degrees of visual field expressed as a slope of a line. 
In another aspect of the invention, the statistical descrip- 
tion further includes a mean of a plurality of slopes. 
In another aspect of the invention, the statistical descrip- 
tion further includes a distribution of a plurality of slopes. 
In another aspect of the invention, the characterization 
includes an area of a visual field defect at a specified contrast 
sensitivity. 
In another aspect of the invention, the characterization 
includes a volume of a visual field defect. 
In another aspect of the invention, the program instruc- 
tions further include generating a diagnosis by comparing 
60 the statistical characterization to a set of statistical charac- 
terizations associated with known causes of visual field 
defects. 
In another aspect of the invention, the program instruc- 
tions further included monitoring the progression of a visual 
65 field defect in the patient’s visual field by comparing the 
statistical characterization to a set of statistical character- 
izations associated with the patient. 
25 
40 the plurality of corresponding patient response signals. 
45 
50 
55  
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BRIEF DESCRIPTION OF THE DRAWINGS tivity levels of a visual field representation in accordance 
with an exemplary embodiment of the present invention; 
FIG. 20 is a process flow diagram of a diagnostic process 
in accordance with an exemplary embodiment of the present 
FIG. 21 is a process flow diagram of a patient monitoring 
process in accordance with an exemplary embodiment of the 
present invention. 
These and other features, aspects, and advantages of the 
present invention will become better understood with regard 
to the following descriptions and accompanying drawings 5 invention; and 
where: 
FIG. 1 is a depiction of an embodiment of a visual field 
measurement system according to the present invention; 
FIG. 2 is a depiction of a cross section of an eye showing 
retinal sensitivity within a retina’s visual field; 10 DETAILED DESCRIPTION 
FIG. 3 is a depiction of an embodiment of a visual field 
test pattern at a low contrast level used to measure a visual FIG. 1 is a depiction of an embodiment of a visual field 
field defect according to an embodiment of the present measurement system according to the present invention. A 
invention; visual field measurement system 100 comprises a computer 
FIG. 4 is a depiction of an embodiment of a visual field 15 system with an electronic display 101 upon which a visual 
test pattern at a high contrast level used to measure a visual field test pattern 102 including a variable fixation point 103 
field defect according to an embodiment of the present is displayed. A patient response input device such as a 
invention; touchscreen 104 is used to record for a patient’s 106 
FIG. 5 is a deployment diagram of an embodiment of a response to the displayed visual field test pattern. 
visual field measurement system according to the present 20 In operation, examination of a patient occurs in an exami- 
invention; nation room with a controlled ambient brightness. The 
FIG. 6 is a deployment diagram of a Web based embodi- patient is positioned in front of the electronic display at a 
ment of a visual field measurement system according to the fixed distance thus determining the angle of the patient’s 
present invention; visual field. The patient’s eye not under examination is 
of a visual field measurement system according to the A visual field test pattern is displayed at a preselected 
present invention; contrast and angular resolution to the patient using the 
FIG. 8 is a state diagram for an analysis state embodiment electronic display. The patient responds to the display of the 
of visual field measurement system according to the present visual field test pattern by selecting locations 107 within the 
invention; 30 field test pattern between areas where the patient clearly sees 
FIG. 9 is an exemplary visual field representation for a the visual field test pattern and areas where the patient is 
patient with “dry” macular degeneration generated from a having difficulty seeing the visual field test pattern. The 
patient response by an embodiment of a visual field mea- patient’s responses are recorded and a visual field represen- 
surement system according to the present invention; tation 108 is generated for diagnostic purposes. 
In another embodiment of a visual field measurement 
visual field measurement system according to the present system according to the present invention, analysis of the 
invention illustrating the generation of a statistical descrip- patient’s responses or the visual field representation occurs 
tion of a patient’s response; at a remote analysis Web server site 110. The visual field 
FIG. 11 is an exemplary visual field representation for a measurement system is operably coupled to the Web server 
patient with glaucoma generated by an embodiment of a 40 via communication links 112 adapted for communications 
visual field measurement system according to the present using Transmission Control ProtocolIInternet Protocol 
invention; (TCPIIP) protocols such as Hyper Text Transfer Protocol 
FIG. 12 is a deployment diagram of an embodiment of a (HTTP) via a communications network such as a Local Area 
distributed diagnostic system according to the present inven- Network (LAN) or a Wide Area Network (WAN) exempli- 
tion; 45 fied by Internet 114. The analysis Web server receives the 
FIG. 13 is a sequence diagram of the operation of a patient’s responses or the visual field representation and 
distributed diagnostic system according to the present inven- makes a comparison to previously received patients’ 
tion; responses or visual field representations. From the compari- 
son, a diagnosis can be made of the patient’s medical 
computer suitable for use as a visual field measurement 50 condition. 
system according to the present invention; FIGS. 15a, 15b, 15c, and 15d are depictions of visual field 
FIGS. 15a, 15b, 15c, and 15d are depictions of visual field test patterns with peripheral fixation points in accordance 
test patterns with peripheral fixation points in accordance with an exemplary embodiment of the present invention. 
with an exemplary embodiment of the present invention; Visual field test patterns with peripheral fixation points 
FIG. 16 is a diagram depicting determining slopes for a 55 allow testing for diseases that manifest themselves in the 
plurality of cross-sections parallel to a visual field axis central vision of a patient, such as macular degeneration, and 
through a visual field representation in accordance with an for testing of larger visual fields with higher eccentricities. 
exemplary embodiment of the present invention; Visual field test pattern 1500 includes peripheral variable 
FIG. 17 is a diagram depicting determining slopes for a fixation point 1502 in an upper right-hand comer of visual 
plurality of cross-sections through the center of a visual field 60 field test pattern 1500. Configured in this manner, visual 
representation in accordance with an exemplary embodi- field test pattern 1500 permits testing of a lower right 
ment of the present invention; quadrant of a patient’s visual field. Visual field test pattern 
FIG. 18 is a histogram of a distribution of slopes deter- 1504 includes peripheral variable fixation point 1506 in an 
mined from a visual field representation in accordance with upper right-hand comer of visual field test pattern 1504. 
an exemplary embodiment of the present invention; 65 Configured in this manner, visual field test pattern 1504 
FIG. 19 is a diagram depicting determining a plurality of permits testing of a lower left quadrant of a patient’s visual 
areas of visual field defects at a plurality of contrast sensi- field. Visual field test pattern 1508 includes peripheral 
FIG. 7 is a state diagram for a tester object embodiment 25 covered with an eye-cover. 
FIG. 10 is an exemplary output from an embodiment of a 35 
FIG. 14 is an architecture diagram for a general purpose 
US 7,101,044 B2 
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variable fixation point 1510 in a lower left-hand comer of 
visual field test pattern 1508. Configured in this manner, 
visual field test pattern 1508 permits testing of an upper right 
quadrant of a patient’s visual field. Visual field test pattern 
1512 includes peripheral variable fixation point 1514 in a 
lower left-hand comer of visual field test pattern 1512. 
Configured in this manner, visual field test pattern 1512 
permits testing of an upper left quadrant of a patient’s visual 
field. In another embodiment of a visual field test pattern in 
accordance with an exemplary embodiment of the present 
6 
300. The lines of the grid are distributed along an X axis 302 
and a Y axis 304 such that when a patient views the visual 
field test pattern presented on the electronic display, the lines 
create a grid within the patient’s visual field. The exact grid 
5 spacing is variable and dependent on testing conditions and 
clinician preference. 
The appearance of a visual field defect is dependent on the 
type of defect present in the retina, optic nerve, or patient’s 
visual processing abilities. In this case, a defect in the visual 
i o  field is presented as an area 308 where the grid is not visible 
invention, a plurality of peripheral fixation points are to the patient. The patient touches the electronic display at 
included in the visual field test pattern. a perimeter location 310 corresponding to an edge of the 
FIG. 2 is a depiction of a cross section of an eye showing area of the visual field defect. A location where the patient 
retinal sensitivity within a retina’s visual field. An eye 200 touches the electronic display is sensed by a touch screen 
partially comprises a cornea 210 and a retina 212. The 15 104 (FIG. 1) and recorded. The patient continues touching 
cornea focuses light rays 218, 220, and 222 onto the retina. the perimeter of the area of the visual field defect describing 
Cells within the retina transduce the incoming light rays into a series of rectilinear locations recorded as the patient’s 
signals via a photochemical reaction. The resultant signals response to the visual field test pattern. These rectilinear 
are transported from the retina to the brain for processing by locations define a perimeter for the visual field defect at a 
an optic nerve 214. The optic nerve is coupled to the retina 20 single contrast level. 
at the optic disk 216. The optic disk is not sensitive to light. FIG. 4 is a depiction of an embodiment of a visual field 
The contrast sensitivity of the retina varies from the test pattern at a high contrast level used to measure a visual 
perimeter of the retina to the center. The retina’s contrast field defect according to an embodiment of the present 
sensitivity is highest at the retina’s center and lowest at the invention. The high contrast visual field test pattern has the 
retina’s perimeter. When plotted along a Y axis 224 versus 25 same overall configuration of the previously described low 
the eccentricity of the retina’s visual field in Degrees along contrast visual field test pattern but the high contrast visual 
an X axis 226, the contrast sensitivity of the retina describes field test pattern is presented to the patient at a high contrast 
a contrast sensitivity curve 228 with several local maxima level. 
and minima. The visual field measurement system presents the visual 
Two contrast sensitivity curve local minima are located on 30 field test pattern to the patient and the patient’s response to 
the portion of the contrast sensitivity curve corresponding to the visual field test pattern is recorded as previously 
the retina’s perimeter of the retina 230 and 232. One contrast described. This time however, the patient may perceive that 
sensitivity curve local minimum 234 is located at the portion the defect in the visual field has grown smaller because the 
of the contrast sensitivity curve associated with the retina’s visual field test pattern has a higher contrast level and is thus 
optical disk. As one moves from the perimeter of the retina 35 easier to see. 
to the center of the retina, the sensitivity of the retina In another embodiment of a visual field test pattern 
increases 236. according to the present invention, the visual field test 
Defects in the retina may cause the retina to lose its pattern is a rectilinear grid known as an Amsler grid. 
contrast sensitivity 240 either partially or totally. This loss in In another embodiment of a visual field test pattern 
contrast sensitivity translates into defects in the visual field. 40 according to the present invention, a fixation point is pre- 
Thus, defects in the retina can be detected by measuring the sented to the patient and the fixation point is varied during 
retina’s visual field. Additionally, defects in the optic nerve the time the visual field test pattern is presented to the 
or in a patient’s ability to process visual information in the patient. For example, the fixation point may be a displayed 
brain may also cause defects in the visual field. letter and the displayed letter is randomly and constantly 
The contrast sensitivity of the retina and pathways can be 45 changed during the time the visual field test pattern is being 
measured by presenting visual field test patterns of differing presented to the patient. 
contrast to a patient. For example, if a first visual field test In another embodiment of a visual field test pattern 
pattern has a high contrast level, as represented by a first according to the present invention, the visual field test 
constant contrast sensitivity 241, the retina detects the visual pattern is varied slightly during the testing period in order to 
field test pattern at locations, 242 and 244, on the contrast 50 mitigate a Troxler effect. Varying the visual field test pattern 
sensitivity curve corresponding to locations on the retina is accomplished be either changing the display position of 
close to the retina’s perimeter. the visual test pattern on a display device or by causing the 
If a second visual field test pattern has a low contrast visual field test pattern to flicker at a frequency selected to 
level, as represented by a second constant contrast sensitiv- mitigate the Troxler effect. 
ity line 246, the retina detects the second visual field test 55 In another visual field test pattern in accordance with an 
pattern at contrast sensitivity curve locations, 248 and 250, exemplary embodiment of the present invention, the color of 
corresponding to locations on the retina close to the retina’s the elements included in the visual field test pattern, such as 
center. In this case, the second test pattern’s contrast is too the previously described grid lines and fixation points, is 
low to be detected by the defective portion of the retina 238. varied. For example, the visual test pattern can be presented 
FIG. 3 is a depiction of an embodiment of a visual field 60 in a single color, such as red, and the contrast levels are 
test pattern at a low contrast level used to measure a visual varied for the visual test pattern in order to elicit a patient 
field according to an embodiment of the present invention. response. In another example, the color of a visual field test 
A visual field measurement system 100 (FIG. 1) presents the pattern is varied, such as first presenting a visual field test 
visual field test pattern to a patient using an electronic pattern in red and then presenting the visual field test pattern 
display 101 (FIG. 1). The visual field test pattern includes a 65 in green, in order to elicit a patient response. In another 
series of vertical lines and horizontal lines substantially example, both the contrast levels and the color are varied in 
orthogonal to one another thus creating a rectilinear grid order to elicit a patient response. 
US 7,101,044 B2 
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FIG. 5 is a deployment diagram of an embodiment of a 
visual field measurement system according to the present 
invention. A visual field measurement system comprises a 
central processor 500 operably coupled to an electronic 
display 502 and a patient response input device 504. 
In one embodiment of a visual field measurement system, 
a personal computer is used with a conventional CRT 
display. The CRT display is modified with a touchscreen 
device so that a patient may simply touch the CRT display 
at the locations where the patient detects a change in the 
appearance of the visual field test pattern. 
In another embodiment of a visual field measurement 
system, the touchscreen device is replaced by a pointing 
device, such as a trackball or mouse, operably coupled to a 
programmatically controlled cursor presented on the elec- 
tronic display along with the visual field test pattern. The 
patient manipulates the cursor to outline the visual field 
defect. 
In another embodiment of a visual field measurement 
system, the cursor is controlled through keyboard inputs. 
In another embodiment of a visual field measurement 
system, a plurality of electronic displays and patient 
response input devices are operably coupled to a single 
central processor. In this case, a plurality of patients may be 
tested at a single time. 
In other embodiments of visual field measurement sys- 
tems, other electronic displays capable of displaying visual 
field test patterns at varying contrast levels are used such as 
projection screens, Liquid Crystal Displays (LCDs), plasma 
displays, etc. 
The visual field measurement system further comprises 
software objects hosted by the central processor. The soft- 
ware objects include a tester 506 operably coupled to the 
electronic display and the patient response device. The tester 
generates visual field test patterns for display to the patient 
using the electronic display. The tester package receives 
patient response signals from the patient response input 
device and records patient responses generated from the 
patient response signals for use by a representation generator 
508. 
The representation generator accepts patient responses 
from the tester and generates a visual field representation 
from the patient response signals suitable for use in a 
diagnostic process. 
In one embodiment of a visual field measurement system, 
the tester is operably coupled to a patient response database 
510. The tester puts the patient response in the patient 
response database along with a patient identification and 
time and date information. A time series of stored patient 
responses taken over time from the same patient is then used 
to watch the progress of a patient’s medical condition. 
In another embodiment of a visual field measurement 
system, the tester puts visual field representations in the user 
response database. The stored visual field representations 
are used in the same manner as the patient responses as 
previously described. 
In another embodiment of a visual field measurement 
system according to the present invention, the tester is 
operably coupled to a statistics generator 512. The statistics 
generator accepts patient responses or visual field represen- 
tations and generates descriptive statistics useful for diag- 
nostic purposes. 
FIG. 6 is a deployment diagram of a Web based embodi- 
ment of a visual field measurement system according to the 
present invention. A client host 600 is operably coupled to 
a server host 602 via a communications link 603 adapted for 
communications using TCPIIP. The client host is operably 
8 
coupled to a previously described electronic display 502 and 
a previously described patient response input device 504. A 
browser 606 hosted by the client host is operably coupled to 
the electronic display and the patient response input device. 
5 The browser requests and receives Web pages from a tester 
Web server 608 hosted by the server host. The Web pages 
served from the tester Web server implement the previously 
described visual field measurement procedure. 
The browser collects patient responses from the response 
lo input device and posts the results to the tester Web server. 
The tester Web server is operably coupled to a previously 
described representation generator 508, patient response 
database 510, and statistics generator 512. The tester Web 
server uses the representation generator to generate visual 
l5 field representations from patient responses as previously 
described and incorporates the visual field representations 
into a Web page that is transmitted back to the browser for 
display. 
FIG. 7 is a state diagram for a tester object embodiment 
of a visual field measurement system according to the 
present invention. A tester software object 506 (FIG. 5) 
performs a setup 700 of the electronic display including 
adjusting the size of the visual field test pattern based on the 
25 size of the electronic display and a distance between a 
patient and the electronic display. Patient information is 
collected for association with the patient response in the 
previously described patient response database. 
A first contrast level is set and a visual field test pattern is 
30 generated 702 for the first contrast level. The visual field test 
pattern is presented to the patient and the collection of 
patient response signals from a previously described patient 
input device begins. 
The tester collects data from the patient response input 
35 device by reading points 706 selected by the patient outlin- 
ing the perimeter of any visual field defect observed by the 
patient. The tester updates 708 the electronic display by 
highlighting the points selected by the patient. 
At the end of the test, a clinician or the patient selects an 
40 area of the visual field test pattern that the patient can see 
clearly 709. This indicates to the tester whether the areas of 
the visual field test pattern within the enclosed perimeter 
outlined by the patient are areas where the patient can see or 
not see the visual field test pattern. For example, in the 
45 previously described high contrast visual field test pattern 
400 (FIG. 4), a patient cannot see the visual field test pattern 
within the area of the visual field defect 402 (FIG. 4). In this 
case, the clinician or patient selects an area of the visual field 
test pattern outside of the visual defect area to indicate that 
50 the patient can see that portion of the visual field test pattern. 
The tester determines if there are more contrast levels to 
test 710 and returns to the visual field test pattern generation 
and contrast setting state 702 and the collect data state 704 
until no more contrast levels are needed. 
In another embodiment of a visual field measurement 
system according to the present invention, the screen update 
at update state 708 includes updating a cursor location 
indicating the position of a displayed cursor responsive to a 
In another embodiment of a visual field measurement 
system according to the present invention, a plurality of 
visual field test patterns with varying contrast levels are 
presented to a patient in order of decreasing or increasing 
In another embodiment of a visual field measurement 
system according to the present invention, a plurality of 
2o 
55 
6o user input device such as a pointing device or track ball. 
6 5  contrast levels. 
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visual field test patterns with varying contrast levels are only a few degrees of visual field. Applying the slope grade 
presented to a patient in random order with respect to the measure, all occurring slopes, e.g., parallel to an X-axis of 
varying contrast levels. the visual field, can then be automatically calculated. Having 
In another embodiment of a visual field measurement calculated all the occurring slopes in one direction the 
system according to the present invention, the visual field 5 average slope and standard variation for that direction can be 
test pattern contains a variable fixation point as previously obtained. Furthermore, a histogram can be generated using 
described. In this case, the tester simultaneously generates all individual slopes for that direction, ranging from shallow 
new fixation points 712 while the tester is collecting patient to steep slopes, to actually result in a slope distribution. The 
responses. The tester constantly determines a new 714 same procedure outlined above can then be applied to other 
fixation point and displays 716 the new fixation point until i o  directions (e.g., parallel to a Y-axis of the visual field, or 
the test is over 718. radially from the center of fixation). 
If no more visual field test patterns for new contrast levels FIG. 16 is a diagram depicting determining slopes for a 
are to be generated 720, the tester moves into an analyze plurality of cross-sections parallel to a visual field axis 
state 722 where the collected data is analyzed for diagnostic through a visual field representation in accordance with an 
purposes. 15 exemplary embodiment of the present invention. Measure- 
FIG. 8 is a state diagram for an analysis state embodiment ment of the change in contrast sensitivity with respect to 
of visual field measurement system according to the present displacement along an axis of a visual field may be deter- 
invention. In the analyze state, the tester generates a to be mined in a plurality of locations. A visual field representa- 
described visual field representation using the previously tion 1514 is displayed in a 3 dimensional graph with contrast 
described patient response data 800. The visual field repre- 20 sensitivity plotted along a vertical axis 1516, degrees of 
sentation can be saved for use in further diagnostic processes visual field in the X direction plotted along an X axis 1518, 
or can be displayed directly to a clinician for diagnostic and degrees of visual field along a Y axis 1520. Cross 
purposes. sections may be taken through the visual field representation 
FIG. 9 is an exemplary visual field representation gener- in a variety of ways and slopes determined along the 
ated by an embodiment of a visual field measurement system 25 cross-section as depicted in FIG. 10. For example, cross 
according to the present invention from a patient response. sections may be taken parallel to the Y axis such as cross 
The visual field representation is a three-dimensional plot of sections 1522, 1524, and 1526. Cross-sections may also be 
contrast sensitivity 904 plotted across a two-dimensional taken parallel to the X axis such as cross-sections 1528, 
visual field comprising an X axis 900 and a Y axis 902 1530, and 1532. 
demarcated in degrees. As previously described, a patient 30 FIG. 17 is a diagram depicting determining slopes for a 
outlines visual field defects on a visual field test pattern plurality of cross-sections through the center of a visual field 
displayed at a plurality of contrast levels. Each of these representation in accordance with an exemplary embodi- 
outlined visual field defects is plotted on a two-dimensional ment of the present invention. Measurements of the change 
plane defined by the contrast sensitivity at which the visual in contrast sensitivity with respect to displacement along the 
field defect was outlined by the patient. This process creates 35 visual field may also be made using cross-sections through 
a three-dimensional visual field representation 908 with the center of a visual field representation. A visual field 
great descriptive power. Returning to FIG. 8, the tester representation 1514 is displayed in a 3 dimensional graph 
generates 802 a statistical description of the patient with contrast sensitivity plotted along a vertical axis 1516, 
response. A statistical description of the patient response is degrees of visual field in the X direction plotted along an X 
used by a diagnostic tool to determine the severity of a visual 40 axis 1518, and degrees of visual field along a Y axis 1520. 
field defect. A statistical description of a visual field defect Cross sections may be taken through the visual field repre- 
is also useful for comparison of a visual field defect to sentation in a variety of ways and slopes determined along 
historical data 804 collected from the patient. the cross-section as depicted in FIG. 10. For example, cross 
FIG. 10 is an exemplary output from an embodiment of a sections may be taken radially from the center of fixation 
visual field measurement system according to the present 45 1604, such as cross-sections 1600 and 1602. 
invention illustrating the generation of a statistical descrip- FIG. 18 is a histogram of a distribution of slopes deter- 
tion of a patient’s response. In this example, the patient’s mined from a visual field representation in accordance with 
response is transformed into a plot of retinal contrast sen- an exemplary embodiment of the present invention. A his- 
sitivity 1002 versus displacement along an X axis of the togram 1700 may be generated for the slopes determined 
visual field. In this case, a defect in the visual field is shown 50 from a visual field representation. The histogram may be 
by a decrease in contrast sensitivity 1004. A line 1006 generated by plotting the relative number of slopes as a 
generated through a linear regression process depicts the percentage along a Y-axis 1702 and slope grade defined as 
steepness of the decline in contrast sensitivity of the retina % contrast sensitivity per degree of visual field along an X 
corresponding to the location of the visual field defect. axis 1704. This results in generating a histogram with a 
In another embodiment of a visual field measurement 55 distinctive pattern that may be used as a statistical measure 
system according to the present invention, the visual field to compare one visual field representation to another. The 
data is presented as a ratio between the loss of contrast comparison may be made between histograms generated 
sensitivity over degrees of visual field taken perpendicularly from a single patient over time in order to monitor the 
to the steepest or shallowest slope, expressed as a grade (?! progression of a visual field defect. The comparison may 
contrast sensitivityidegree). 60 also be made between different patients, such as a first 
As an example measure for the slope calculation a slope patient with a visual field defect having a known cause and 
grade can be defined as the percentage of retinal contrast a second patient having a visual field defect with an 
sensitivity loss over degrees of visual field. A shallow slope unknown cause in order to generate a diagnosis for the 
would then be characterized as a percentage of retinal second patient. 
contrast sensitivity loss along a larger number of degrees of 65 Referring again to FIG. 9, in another embodiment of a 
visual field, whereas a steep slope would be characterized as visual field measurement system according to the present 
a large percentage of retinal contrast sensitivity loss along invention, a visual field defect is characterized by a ratio of 
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an area of the visual field defect at a highest measured tion. A plurality of visual field measurement systems as 
contrast sensitivity 914 versus an area of the visual field exemplified by visual field measurement system 100 are 
defect at a lowest measured contrast sensitivity 916. operably coupled to a diagnostic host 1200 via a commu- 
FIG. 19 is a diagram depicting determining a plurality of nications link 1202 adapted for communications using TCPi 
areas of visual field defects at a plurality of contrast sensi- 5 IP. The diagnostic host hosts a diagnostic Web server oper- 
tivity levels of a visual field representation in accordance 
with an exemplary embodiment of the present invention. A 
visual field representation 1514 is displayed in a 3 dimen- 
sional graph with contrast sensitivity plotted along a vertical 
axis 1516, degrees of visual field in the X direction plotted 
along an X axis 1518, and degrees of visual field along a Y 
axis 1520. Sections may be taken through the visual field 
representation at various percent contrast sensitivities, such 
as sections 1800, 1802, 1804, and 1806. The area of visual 
field loss as a function of contrast sensitivitv can be calcu- 
ably coupled to a previously described tester software 
module 1206 through the communications link. The diag- 
nostic Web server is also operably coupled to a diagnostics 
generator such as anArtificia1 Intelligence (Al) engine 1208. 
i o  The A1 engine is also operably coupled to a diagnostic 
database. The diagnostic database includes a set of visual 
field representations mapped to a set of diagnoses. 
FIG. 13 is a sequence diagram of the operation of a 
distributed diagnostic system according to the present inven- 
15 tion. In oneration. a visual field measurement svstem 100 
lated for these sections by automatically counting grid- performs a visual field measurement acquiring a patient’s 
points (usually one grid-point corresponds to an area of one responses and generates a visual field representation as 
deg’) that have been marked by a patient and thus calculate previously described. A clinician performs an independent 
the area of visual field loss at the presented contrast level. analysis of the patient and generates a diagnosis with a high 
The percentage of visual field loss at a presented contrast 20 confidence factor. The clinician transmits the visual field 
level is calculated by dividing the number of marked grid- representation and diagnosis 1300 to a diagnostic server 
points by the total number of presented grid-points at that 1200. The diagnostic server generates a database record 
contrast level. In addition, an overall volume of visual field 1302 correlating the visual field representation and the 
loss as compared to a “normal” hill-of-vision may be diagnosis and puts the data record in the diagnostic database 
calculated by automatically counting all the grid-points of 25 1210. 
all presented contrast levels that have been marked by the This process is repeated 1304, building a set of a set of 
patient and divide by the total number of grid-points of all visual field representations mapped to a set of diagnoses in 
presented contrast levels to obtain the percentage of volume the diagnostic database. 
of visual field loss compared to a “normal” hill-of-vision. To determine a diagnosis, a visual field measurement 
Referring again to FIG. 8, statistical descriptions of 30 system 100 performs a visual field measurement acquiring a 
patient’s responses and visual field representations are used patient’s responses and generates a visual field representa- 
by the tester to track the progress of an ailment affecting the tion as previously described. 
visual field. In a history 804 state, the tester generates time The visual field measurement system transmits the visual 
series of either statistical descriptions or visual field repre- field representation 1306 to the diagnostic server and the 
sentations for use by a clinician in monitoring the progress 35 diagnostic server transmits the visual field representation 
of an ailment. 1308 to the AI engine. 
Visual field representations are used to create a diagnostic The AI engine receives the visual field representation and 
tool using artificial intelligence to diagnose a patient’s gets the set of visual field representations mapped to a set of 
ailments affecting the visual field. For example, patients diagnoses 1310 from the diagnostic database. The AI engine 
suffering from macular degeneration experience a loss of 40 searches the set of visual field representations for visual field 
vision because of impairments of the central retina and thus representations with a high correlation to the received visual 
will have trouble seeing the visual field test pattern near the field representation using pattern matching techniques 1312. 
center fixation point. Since macular degeneration sufferers If a matching database visual field representation is found, 
have peripheral vision, they would likely outline a central the AI engine transmits a diagnosis 1314 associated with the 
hole on the screen, and if they also had a relative visual field 45 database visual field to the diagnostics Web server. 
defect, they might trace an ever-smaller circle as the contrast The diagnostic Web server generates 1316 a diagnostic 
of the visual field test pattern increased. Web page 1318 using the diagnosis and transmits the diag- 
Referring again to FIG. 9, the visual field representation nostic Web page to the visual field measurement system. 
for a patient with “dry” macular degeneration is character- FIG. 20 is a process flow diagram of a diagnostic process 
ized by a peripheral area 910 of high contrast sensitivity. In 50 in accordance with an exemplary embodiment of the present 
the center of the visual field 912, the contrast sensitivity invention. A diagnostic process 1312 is one process used by 
drops off significantly creating a hole in the visual field an AI engine to detect and diagnose visual field defects. The 
representation. diagnostic process receives (1900) a patient visual field 
FIG. 11 is an exemplary visual field representation for a representation 1306 from a visual field measurement system. 
patient with glaucoma generated by an embodiment of a 55 The diagnostic process uses the patient visual field repre- 
visual field measurement system according to the present sentation to calculate (1902) statistical values for the patient 
invention. A glaucoma patient is most likely to experience a visual field representation as previously described. The 
loss of retinal contrast sensitivity at the periphery of the statistical values may include the areas of visual field loss as 
retina. Thus a glaucoma patient will outline a central area a function of contrast sensitivity, overall volume of visual 
1100 of high contrast sensitivity surrounded by an area 1102 60 field loss as compared to a “normal” visual field represen- 
of low contrast sensitivity. tation, and slope distributions of scotoma boundaries. 
The distinctive characteristics of visual field representa- The diagnostic process compares (1904) the areas of 
tions are used as the basis of a diagnostic tool employing visual field loss as a function of contrast sensitivity calcu- 
pattern matching to determine a diagnosis from a visual field lated using the patient visual field representation to areas of 
representation created from a patient’s responses. 65 visual field loss as a function of contrast sensitivity corre- 
FIG. 12 is a deployment diagram of an embodiment of a lated to specific diseases 1905 stored in a diagnostic data- 
distributed diagnostic system according to the present inven- base 1210. The diagnostic process may also compare (1906) 
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overall volume of visual field loss calculated from the are stored on the disk storage device until the microproces- 
patient visual field representation to overall volumes of sor retrieves the computer program instructions and stores 
visual field loss correlated to specific diseases 1907 stored in them in the main memory. The microprocessor then executes 
the diagnostic database. The diagnostic process may also the computer program instructions stored in the main 
compare (1908) the slope distributions of scotoma bound- 5 memory to instantiate a visual field measurement system. 
aries calculated from the patient visual field representation Although this invention has been described in certain 
to slope distributions of scotoma boundaries correlated to specific embodiments, many additional modifications and 
specific diseases 1909 stored in the diagnostic database. variations would be apparent to those skilled in the art. It is 
The diagnostic process then uses the comparisons to therefore to be understood that this invention may be prac- 
generate (1910) a diagnosis 1314 of the cause of a patient’s i o  ticed otherwise than as specifically described. Thus, the 
visual field defect. For example, if all the patient’s statistical present embodiments of the invention should be considered 
values match all of the statistical values correlated to a in all respects as illustrative and not restrictive, the scope of 
specific disease, the diagnostic process can determine with the invention to be determined by claims supported by this 
a high degree of certainty that the patient has that specific application and the claim’s equivalents rather than the 
disease. 15 foregoing description. 
FIG. 21 is a process flow diagram of a patient monitoring What is claimed is: 
process in accordance with an exemplary embodiment of the 1. A method of objectively characterizing a patient’s 
present invention. Apatient monitoring process 2000 may be visual field, comprising: 
used by an AI engine to track the progression of an indi- repeating steps a and b for a plurality of varying contrast 
vidual patient’s visual field defect. The patient monitoring 20 levels and a plurality of corresponding patient response 
process receives (2001) a patient visual field representation signals: 
1306 from a visual field measurement system. The patient a) presenting a visual field test pattern to the patient 
monitoring process uses the patient visual field representa- using an electronic display device, the visual field 
tion to calculate (2002) statistical values for the patient test pattern presented at a contrast level selected 
visual field representation as previously described. The 25 from the plurality of varying contrast levels; 
statistical values may include the areas of visual field loss as b) receiving a corresponding patient response signal; 
a function of contrast sensitivity, overall volume of visual and 
field loss as compared to a “normal” visual field represen- generating a characterization of the patient’s visual field 
tation, and slope distributions of scotoma boundaries. using the plurality of contrast levels and the plurality of 
corresponding patient response signals. 
patient’s areas of visual field loss as a function of contrast 2. The method of claim 1, wherein the characterization 
sensitivity calculated using the patient visual field represen- includes a statistical description of a boundary of a visual 
tation to areas of visual field loss as a function of contrast field defect. 
sensitivity, overall volume of visual field loss, and slope 3. The method of claim 2, wherein the statistical descrip- 
distributions of scotoma boundaries calculated from the 35 tion includes a percentage of retinal contrast sensitivity loss 
patient visual field representation to the patient’s own his- over degrees of visual field expressed as a slope of a line. 
tory 2006. The current patient values are then stored (2008) 4. The method of claim 3, wherein the statistical descrip- 
as part of the patient’s history for further use. The diagnostic tion further includes a mean of a plurality of slopes. 
process then uses the comparisons to generate (2010) a 5. The method of claim 3, wherein the statistical descrip- 
report 2012 of the progression of the patient’s visual field 40 tion further includes a distribution of a plurality of slopes. 
defect. 6. The method of claim 1, wherein the characterization 
FIG. 14 is an architecture diagram for a general purpose includes an area of a visual field defect at a specified contrast 
computer suitable for use as a visual field measurement sensitivity. 
system according to the present invention. A microprocessor 7. The method of claim 1, wherein the characterization 
1400, including a Central Processing Unit (CPU) 1410, a 45 includes a volume of a visual field defect. 
memory cache 1420, and a bus interface 1430, is operably 8. The method of claim 1, the method further comprising 
coupled via system bus 1435 to a main memory 1440 and an generating a diagnosis by comparing the statistical charac- 
IiO control unit 1445. The IiO interface control unit is terization to a set of statistical characterizations associated 
operably coupled via an IiO local bus 1450 to a disk storage with known causes of visual field defects. 
controller 1495, a video controller 1490, a keyboard con- 50 9. The method of claim 1, the method further comprising 
troller 1485, a network controller 1480, and an IiO device monitoring the progression of a visual field defect in the 
controller 1475. The disk storage controller is operably patient’s visual field by comparing the statistical character- 
coupled to a disk storage device 1455 for storage and ization to a set of statistical characterizations associated with 
retrieval of computer instructions 1497 and data. The video the patient. 
controller is operably coupled to an electronic display device 55 10. A data processing apparatus for objectively charac- 
1460 for display of visual field test patterns to a patient. The terizing a patient’s visual field, comprising: 
keyboard controller is operably coupled to a keyboard 1465 a processor; and 
for input of commands to the visual field measurement a memory coupled to the processor, the memory having 
system. The network controller is operably coupled to a program instructions executable by the processor 
communications device 1496. The communications device 60 stored therein, the program instructions including: 
is adapted to allow software objects hosted by the general repeating steps a and b for a plurality of varying 
purpose computer to communicate via a network with other contrast levels and a plurality of corresponding 
software objects. The IiO device controller is operably patient response signals: 
coupled to a patient response input device 1498 for input of a) presenting a visual field test pattern to the patient 
patient responses to the visual field test pattern. using an electronic display device, the visual field 
Computer program instructions 1497 implementing soft- test pattern presented at a contrast level selected 
ware objects comprising a visual field measurement system from the plurality of varying contrast levels; 
The patient monitoring process compares (2004) the 30 
6 5  
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b) receiving a corresponding patient response signal; 15. The data processing apparatus of claim 10, wherein 
the characterization includes an area of a visual field defect 
generating a characterization of the patient’s visual at a specified contrast sensitivity. 
field using the plurality of contrast levels and the 16. The data processing apparatus of claim 10, wherein 
plurality of corresponding patient response signals. 5 the characterization includes a volume of a visual field 
11. The data processing apparatus of claim 10, wherein defect. 
the characterization includes a statistical description of a 17. The data processing apparatus of claim 10, the pro- 
boundary of a visual field defect. gram instructions further including generating a diagnosis 
12. The data processing apparatus of claim 11, wherein by comparing the statistical characterization to a set of 
the statistical description includes a percentage of retinal i o  statistical characterizations associated with known causes of 
contrast sensitivity loss over degrees of visual field visual field defects. 
expressed as a slope of a line. 18. The data processing apparatus of claim 10, the pro- 
13. The data processing apparatus of claim 12, wherein gram instructions further including monitoring the progres- 
the statistical description further includes a mean of a sion of a visual field defect in the patient’s visual field by 
plurality of slopes. 15 comparing the statistical characterization to a set of statis- 
14. The data processing apparatus of claim 11, wherein tical characterizations associated with the patient. 
the statistical description further includes a distribution of a 
and 
plurality of slopes. * * * * *  
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